←Back to Expert Scholars
Translational Medicine / 转化医学Hairy Cell Leukemia and CLL
Kerry Rogers
MD
🏢The Ohio State University🌐USA
Associate Professor, Division of Hematology
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kerry Rogers leads trials evaluating targeted therapies including BTK inhibitors and venetoclax across CLL and hairy cell leukemia. Her work on rare B cell malignancies has defined new treatment options for previously limited populations. She is active in Alliance cooperative group leukemia trials.
Share:
🧪Research Fields 研究领域
hairy cell leukemia
CLL
BTK inhibitors
rare leukemias
targeted therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kerry Rogers 的研究动态
Follow Kerry Rogers's research updates
留下邮箱，当我们发布与 Kerry Rogers（The Ohio State University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment